ROBERT W. ROSS
CIK 1733077 · Chief Executive Officer · last filed 2025-06-12
ROBERT W. ROSS is a Chief Executive Officer who has filed 21 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for XLO, was dated Jun 12, 2025. Across all open-market trades the lifetime net is −$428.6K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
21
-$428.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XLO | Director | — | $8.31 | — | $0 | 4 | 2025-06-12 |
| Surface Oncology, Inc. (SURF) Delisted | Chief Executive Officer | 0 | $1.07 | $0 | -$428.6K | 17 | 2023-09-08 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-12 | XLO | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | XLO | Grant (A) | — | $0 | EDGAR |
| 2023-09-08 | Surface Oncology, Inc. (SURF) Delisted | Disp (D) | −83,193 | $0 | EDGAR |
| 2023-08-11 | Surface Oncology, Inc. (SURF) Delisted | Sell (S) | −16,713 | -$15.7K | EDGAR |
| 2023-06-13 | XLO | Grant (A) | — | $0 | EDGAR |
| 2023-03-03 | Surface Oncology, Inc. (SURF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-05 | Surface Oncology, Inc. (SURF) Delisted | Sell (S) | −10,594 | -$18.2K | EDGAR |
| 2022-06-17 | XLO | Grant (A) | — | $0 | EDGAR |
| 2022-03-03 | Surface Oncology, Inc. (SURF) Delisted | Grant (A) | +56,000 | $0 | EDGAR |
| 2022-01-14 | Surface Oncology, Inc. (SURF) Delisted | Sell (S) | −33,500 | -$204.3K | EDGAR |